Present and future etiological treatment of bacterial pneumonia 3. The antibacterial drugs under development
Journal Title: Здоров`я дитини - Year 2017, Vol 12, Issue 5
Abstract
The rapid spread of antibiotic-resistant bacterial strains necessitates the development of new antibacterial agents and a review of the guidelines for etiological treatment of bacterial infections, including pneumonia. Currently, new antibacterial agents are being developed that disrupt the biosynthesis of peptidoglycan, teichoic and lipoteichoic acids, and also block the attachment of virulent factors to the bacterial wall. New molecules of old classes of antibiotics and representatives of new classes of antibiotics with their targets (lipid II and III, teichoic and lipoteichoic acids, alanine racemase, and sortase A) will become practical tools in clinical practice in the very near future. The goals and mechanisms of action of new antibacterial compounds predetermine their clinical prospects in future strategies for the treatment of infectious bacterial diseases.
Authors and Affiliations
А. Е. Abaturov, Т. А. Kryuchko
Keywords
Related Articles
- EP ID EP221470
- DOI 10.22141/2224-0551.12.5.2017.109278
- Views 91
- Downloads 0
Microaspiration Syndrome in Pediatric Practice: Modern Features and Role in Bronchial Obstruction Syndrome Formation
The paper presents the data on research of aspiration syndrome prevalence among young children treated in the City children’s pulmonary department due to protracted course of obstructive bronchitis. The structure of micr...
Prediction of the Individual Risk of Bronchial Obstruction in Acute Bronchitis in Infants
The objective of the study was to determine highly informative clinical-anamnestic, immunological and molecular-genetic risk factors of bronchial obstruction in acute bronchitis in infants. Methods. We have evaluated the...
Acute Pharyngitis in Children: Issues of Etiology and Treatment
Article is devoted to the issues of rational treatment of acute pharyngitis in children with acute respiratory viral infections. Attention is given to herbal preparations, namely Tonsipret®, which has a pronounced analge...
Experience with Ivy Leaf Extract in the Treatment of Acute Obstructive Bronchitis in Children
According to the World Health Organization, when analyzing the structure of the causes of visiting to the pediatrician or general practitioner — family doctor, about 70 % of cases occur in acute respiratory infections (...
Efficacy of noofen use in the treatment of gastroesophageal reflux disease in schoolchildren
We examined 40 children aged 10–18 years, who were diagnosed with gastroesophageal reflux disease (GERD). According to a survey by O.M. Vein, all patients had manifestations of autonomic dysfunction. The children were di...